Structural Biology and Molecular Modelling Market: By Software Type (Molecular Visualisation, Molecular Mechanics, Semi-empirical Molecular Orbital, Ab initio Molecular Orbital, Integrated Environments, Chemical Sketcher, Threading, DNA & RNA Structure Predictor, Gene and Protein Sequence Alignment, Phylogenetic Search and Analysis, Crystallography and NMR, Genetic and Molecular Database Handling, Molecular Dynamics Simulations, Mathematical and Statistical Manipulation, Molecular Docking, Quantum Chemistry Calculation Others) Application (Small Molecule Drug Discovery, Biologics Drug Discovery, Drug Designing, Drug- Receptor Interaction Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Global Structural Biology and Molecular Modelling Market Introduction
2.1. Global Structural Biology and Molecular Modelling Market – Taxonomy
2.2. Global Structural Biology and Molecular Modelling Market –Definitions
2.2.1. Software Type
2.2.2. Application
2.2.3. Region
3. Global Structural Biology and Molecular Modelling Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Structural Biology and Molecular Modelling Market Dynamic Factors - Impact Analysis
3.6. Impact of COVID-19 on The Market
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Players’ Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Structural Biology and Molecular Modelling Market Forecast, By Software Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.1. Molecular Visualization
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Molecular Mechanics
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Semi-empirical Molecular Orbital
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Ab initio Molecular Orbital
5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Integrated Environments
5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Chemical Sketcher
5.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Threading
5.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. DNA & RNA Structure Predictor
5.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Gene and Protein Sequence Alignment
5.9.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Phylogenetic Search and Analysis
5.10.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
5.11. Crystallography and NMR
5.11.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.11.3. Market Opportunity Analysis
5.12. Genetic and Molecular Database Handling
5.12.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.12.3. Market Opportunity Analysis
5.13. Molecular Dynamics Simulations
5.13.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.13.3. Market Opportunity Analysis
5.14. Mathematical and Statistical Manipulation
5.14.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.14.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.14.3. Market Opportunity Analysis
5.15. Molecular Docking
5.15.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.15.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.15.3. Market Opportunity Analysis
5.16. Quantum Chemistry Calculation
5.16.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.16.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.16.3. Market Opportunity Analysis
5.17. Others
5.17.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.17.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.17.3. Market Opportunity Analysis
6. Global Structural Biology and Molecular Modelling Market Forecast, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.1. Small Molecule Drug Discovery
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Biologics Drug Discovery
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Drug Designing
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Drug-Receptor Interaction
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Structural Biology and Molecular Modelling Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Distribution Channel, Application, and Region, 2022 - 2028
8. North America Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
8.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.1.1. Molecular Visualisation
8.1.2. Molecular Mechanics
8.1.3. Semi-empirical Molecular Orbital
8.1.4. Ab initio Molecular Orbital
8.1.5. Integrated Environments
8.1.6. Chemical Sketcher
8.1.7. Threading
8.1.8. DNA & RNA Structure Predictor
8.1.9. Gene and Protein Sequence Alignment
8.1.10. Phylogenetic Search and Analysis
8.1.11. Crystallography and NMR
8.1.12. Genetic and Molecular Database Handling
8.1.13. Molecular Dynamics Simulations
8.1.14. Mathematical and Statistical Manipulation
8.1.15. Molecular Docking
8.1.16. Quantum Chemistry Calculation
8.1.17. Others
8.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Small Molecule Drug Discovery
8.2.2. Biologics Drug Discovery
8.2.3. Drug Designing
8.2.4. Drug- Receptor Interaction
8.2.5. Others
8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028
8.5. North America Structural Biology and Molecular Modelling Market Dynamics – Trends
9. Europe Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
9.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.1.1. Molecular Visualisation
9.1.2. Molecular Mechanics
9.1.3. Semi-empirical Molecular Orbital
9.1.4. Ab initio Molecular Orbital
9.1.5. Integrated Environments
9.1.6. Chemical Sketcher
9.1.7. Threading
9.1.8. DNA & RNA Structure Predictor
9.1.9. Gene and Protein Sequence Alignment
9.1.10. Phylogenetic Search and Analysis
9.1.11. Crystallography and NMR
9.1.12. Genetic and Molecular Database Handling
9.1.13. Molecular Dynamics Simulations
9.1.14. Mathematical and Statistical Manipulation
9.1.15. Molecular Docking
9.1.16. Quantum Chemistry Calculation
9.1.16.1. Others
9.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Small Molecule Drug Discovery
9.2.2. Biologics Drug Discovery
9.2.3. Drug Designing
9.2.4. Drug- Receptor Interaction
9.2.5. Others
9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028
9.5. Europe Structural Biology and Molecular Modelling Market Dynamics – Trends
10. Asia-Pacific Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
10.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Molecular Visualisation
10.1.2. Molecular Mechanics
10.1.3. Semi-empirical Molecular Orbital
10.1.4. Ab initio Molecular Orbital
10.1.5. Integrated Environments
10.1.6. Chemical Sketcher
10.1.7. Threading
10.1.8. DNA & RNA Structure Predictor
10.1.9. Gene and Protein Sequence Alignment
10.1.10. Phylogenetic Search and Analysis
10.1.11. Crystallography and NMR
10.1.12. Genetic and Molecular Database Handling
10.1.13. Molecular Dynamics Simulations
10.1.14. Mathematical and Statistical Manipulation
10.1.15. Molecular Docking
10.1.16. Quantum Chemistry Calculation
10.1.16.1. Others
10.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Small Molecule Drug Discovery
10.2.2. Biologics Drug Discovery
10.2.3. Drug Designing
10.2.4. Drug- Receptor Interaction
10.2.5. Others
10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028
10.5. Asia-Pacific Structural Biology and Molecular Modelling Market Dynamics – Trends
11. Latin America Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
11.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Molecular Visualisation
11.1.2. Molecular Mechanics
11.1.3. Semi-empirical Molecular Orbital
11.1.4. Ab initio Molecular Orbital
11.1.5. Integrated Environments
11.1.6. Chemical Sketcher
11.1.7. Threading
11.1.8. DNA & RNA Structure Predictor
11.1.9. Gene and Protein Sequence Alignment
11.1.10. Phylogenetic Search and Analysis
11.1.11. Crystallography and NMR
11.1.12. Genetic and Molecular Database Handling
11.1.13. Molecular Dynamics Simulations
11.1.14. Mathematical and Statistical Manipulation
11.1.15. Molecular Docking
11.1.16. Quantum Chemistry Calculation
11.1.16.1. Others
11.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Small Molecule Drug Discovery
11.2.2. Biologics Drug Discovery
11.2.3. Drug Designing
11.2.4. Drug- Receptor Interaction
11.2.5. Others
11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028
11.5. Latin America Structural Biology and Molecular Modelling Market Dynamics – Trends
12. Middle East and Africa Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
12.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Molecular Visualisation
12.1.2. Molecular Mechanics
12.1.3. Semi-empirical Molecular Orbital
12.1.4. Ab initio Molecular Orbital
12.1.5. Integrated Environments
12.1.6. Chemical Sketcher
12.1.7. Threading
12.1.8. DNA & RNA Structure Predictor
12.1.9. Gene and Protein Sequence Alignment
12.1.10. Phylogenetic Search and Analysis
12.1.11. Crystallography and NMR
12.1.12. Genetic and Molecular Database Handling
12.1.13. Molecular Dynamics Simulations
12.1.14. Mathematical and Statistical Manipulation
12.1.15. Molecular Docking
12.1.16. Quantum Chemistry Calculation
12.1.16.1. Others
12.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Small Molecule Drug Discovery
12.2.2. Biologics Drug Discovery
12.2.3. Drug Designing
12.2.4. Drug- Receptor Interaction
12.2.5. Others
12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028
12.5. MEA Structural Biology and Molecular Modelling Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Software Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Dassault Systèmes
13.2.2. Agile Molecule
13.2.3. Agilent Technologies, Inc.
13.2.4. Acellera Ltd.
13.2.5. ThermoFisher Scientific
13.2.6. Schrodinger
13.2.7. Affymetrix
13.2.8. Bioinformatic LLC
13.2.9. Biomax Informatics AG
13.2.10. Bruker Daltonics Inc.
13.2.11. Chemical Computing Group
13.2.12. CLC bio
13.2.13. Dassault Systemes
13.2.14. Illumina
14. Research Methodology
15. Key Assumptions and Acronyms

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Dassault Systèmes
  • Agile Molecule
  • Agilent Technologies, Inc.
  • Acellera Ltd.
  • ThermoFisher Scientific
  • Schrodinger
  • Affymetrix
  • Bioinformatic LLC
  • Biomax Informatics AG
  • Bruker Daltonics Inc.
  • Chemical Computing Group
  • CLC bio
  • Dassault Systemes
  • Illumina

Adjacent Markets